Researchers from Inocras, a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to ...

Dayhoff Health and AMD publish a joint white paper documenting up to 330× faster microbiome processing, 13–22× faster ...

Highlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, ...

Dr. Matthew Lewis discusses why data quality is fundamental to metabolomics research, how AI‑ready workflows and upgradeable ...

GPT-Rosalind steps in the earliest and most hypothesis-driven stages, where researchers juggle vast literature, specialised ...

Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...

Rosalind, an artificial intelligence model designed to support research in biology, drug discovery, and translational medicine. The model is optimized for scientific workflows, combining tool use with ...

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...

Illumina and D3b bring genomic data and scalable software to the fight against paediatric cancer and rare disease: San Diego Thursday, April 16, 2026, 11:00 Hrs [IST] Illumina, an ...

Illumina (NASDAQ: ILMN) and the Center for Data-Driven Discovery in Biomedicine (D3b) today announced a data partnership to advance research in pediatric cancer and rare disease. Through cloud-based ...

Rosalind, a biological language model for target discovery and genomics. Currently only available for US corporate customers.

Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...